What is Dianthus Therapeutics's R&D?

Dianthus Therapeutics (DNTH) reported R&D of $34.53M in Q1 2026.

How has Dianthus Therapeutics's R&D changed year-over-year?

Dianthus Therapeutics's R&D increased by 27.9% year-over-year, from $27M to $34.53M.

What is the long-term trend for Dianthus Therapeutics's R&D?

Over 3 years (2021 to 2024), Dianthus Therapeutics's R&D has grown at a 23.4% compound annual growth rate (CAGR), from $46.77M to $87.9M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Dianthus Therapeutics DNTH R&D

R&D at other companies

AmgenAMGN

$1.72B+15.7%

Spyre Therapeutics, Inc.SYRE

$60.41M+45.1%

Kymera TherapeuticsKYMR

$98.16M+22.3%

Protagonist TherapeuticsPTGX

$46.74M+30.2%

TG TherapeuticsTGTX

$48.4M+4.4%

Immunovant, Inc.IMVT

$142.29M+51.9%

Segments

By product

See full

Personnel And Related Costs$8.64M+47.7%

Share Based Compensation Expense$4.85M—

Other Costs$1.49M+25.5%

Discovery Expenses$1.36M+51.4%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's R&D?: Dianthus Therapeutics (DNTH) reported R&D of $34.53M in Q1 2026.
How has Dianthus Therapeutics's R&D changed year-over-year?: Dianthus Therapeutics's R&D increased by 27.9% year-over-year, from $27M to $34.53M.
What is the long-term trend for Dianthus Therapeutics's R&D?: Over 3 years (2021 to 2024), Dianthus Therapeutics's R&D has grown at a 23.4% compound annual growth rate (CAGR), from $46.77M to $87.9M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.